The Wall Street Journal reported on December 9 that the U.S. Food and Drug Administration (FDA) has revisedModernaPfizer's new version of the COVID-19 vaccine has been granted Emergency Use Authorization, authorizing its use in infants as young as six months.
The new authorization means that children aged between 6 months and 5 years who have received the original two dosesModernaCOVID-19 Vaccine: Updated Booster Shots Targeting the Latest Virus Strains Now Available for Vaccination.